增长因子应用和临床翻译:进步和挑战
Yuhan Tu1,2, Bin Li2, Sainan Zheng1
1Department of Pharmacy, Yueqing Third People's Hospital, Wenzhou, P.R. China.
Annals of medicine
|March 16, 2026
概括
增长因子 (GFs) 显示出治疗前景,但在交付和成本方面面临挑战. 本综述探讨了诸如蛋白质工程和先进的传递系统等解决方案,以增强再生医学和疾病治疗的GF疗法.
科学领域:
- 生物技术是生物技术.
- 生物医学工程 生物医学工程
- 分子生物学分子生物学
背景情况:
- 增长因子 (GFs) 对细胞过程至关重要,在再生医学,瘤学和代谢调节中具有治疗潜力.
- 由于药物动力学限制,非目标效应,安全性问题,高生产成本和复杂的活体环境,GFs的临床转化受到阻碍.
- 尽管在稳定性,准性和安全性方面取得了进展,但对于广泛的GF临床应用仍然存在重大障碍.
研究的目的:
- 系统地审查增长因子 (GF) 的分类和研究进展.
- 分析GF在神经退行性疾病,骨再生和代谢障碍中的当前应用.
- 识别和解决临床翻译GF疗法的关键挑战.
主要方法:
- 基本研究的审查和增长因素 (GF) 的分类.
- 分析目前GF临床翻译中的治疗应用和挑战.
- 解决方案的总结包括蛋白质工程,化学修饰和先进的输送系统.
主要成果:
- GF在治疗神经退行性疾病,骨缺陷和代谢障碍方面已经显示出潜力.
- 确定的主要挑战包括非最佳的药理动力学,输送精度,副作用和高生产成本.
- 解决方案包括结构优化,智能传递系统 (例如,细胞外囊泡) 和顺序释放技术.
结论:
- 提供了全面的路线图和技术参考,以加快下一代GF治疗的发展.
- 未来的研究应该优先考虑可扩展的交付平台,通过合成生物学降低成本,以及基于生物标志物的转化研究.
- 多学科整合对于推动GF疗法在精准医学中的精确性,安全性和有效性至关重要.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
14.6K
09:19High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
11.3K
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
02:38Mitogens and the Cell Cycle
8.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
00:59Gene Therapy
28.0K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.0K
01:19Clinical Applications of Epidermal Stem Cells
3.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K
01:28Role of Hematopoietic Growth Factors
4.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.3K
00:49What is Genetic Engineering?
81.1K
Overview
81.1K